The Pacific Alzheimer Research Foundation (PARF) believes that a well coordinated national strategy is crucial to address Canada’s dementia crisis.
On June 17th, 2019, the Canadian Federal Government announced Canada’s National Dementia Strategy. We had hoped the Strategy would meet or exceed the Canadian Senate’s recommendation to increase research funding to the Canadian Institutes of Health Research to identify a cure by 2025. The Senate was advised that the required funding level was approximately $100 million per year, a 150% increase over current Federal research funding levels.
Disappointingly, Canada’s National Dementia Strategy was only allocated about $10 million per year until 2025, and the actual search for a cure will see very little, if any, increase in Federal funding.
Strong research initiatives on prevention and advancing therapies to find a cure are imperative. It now appears the only way to meet these main objectives of the National Dementia Strategy is if private donations increase to supplement the limited federal funding, while encouraging greater federal support in the future.
PARF has been funding dementia research in BC for over a decade and our experience with the provincial government, post-secondary institutes, funding partners and individual donors has placed us in a unique position. We work with these key stakeholders but are not tied to any one organization or their administration cost. Importantly, 100% of all public donations to PARF are used to fund research, not administration.
PARF is devoted to supporting research into the causes, prevention, and treatment of Alzheimer’s disease and related dementias. Our mission is to eradicate these illnesses by assisting scientists whose aim is to achieve this objective.
Please consider helping to make this important work possible.